Alpa Laboratories Limited
NSE:ALPA.NS
111.64 (INR) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Alpa Laboratories Limited |
Symbool | ALPA.NS |
Munteenheid | INR |
Prijs | 111.64 |
Beurswaarde | 2,348,972,584 |
Dividendpercentage | 0% |
52-weken bereik | 69.9 - 144.5 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Mahendra Singh Chawla |
Website | https://www.alpalabs.in |
An error occurred while fetching data.
Over Alpa Laboratories Limited
Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (INR)
Cijfers zijn in miljoenen (INR)